Understanding the Growing Burden

Recognizing the diabetes infection risk is now vital for clinicians managing metabolic disorders. New evidence highlights that infections are not just incidental issues but severe, underrecognized complications across the diabetes spectrum. This increased risk affects individuals with type 1 (T1D), type 2 (T2D), and even those in the prediabetes range. Consequently, healthcare providers must adopt more aggressive screening and management strategies to reduce overall morbidity.

Researchers recently analyzed comprehensive data from 800,000 individuals to quantify these clinical risks. Specifically, they found that T1D patients face the highest relative risk, showing a 337% increase in infection-related hospitalizations. While T2D and prediabetes show lower relative risks, the sheer volume of cases makes their absolute population burden substantial. Furthermore, the data indicates that infection is now the third leading cause of death in T2D patients, trailing only cardiovascular disease and cancer. This mortality risk often goes underreported because sepsis is rarely listed as the primary cause on death certificates.

Managing the Diabetes Infection Risk Through Glycemic Stability

Notably, the study identified two major glycemic factors that drive these outcomes: average HbA1c levels and visit-to-visit variability. For patients with T1D, higher average HbA1c levels strongly correlate with infection susceptibility. In contrast, T2D patients appear more sensitive to HbA1c variability. Therefore, stabilizing glucose levels over time may be just as important as reaching a specific target level. Additionally, South Asian populations carry a disproportionately high burden of these complications. Since India manages a vast number of South Asian patients, these findings necessitate urgent local clinical adjustments. Physicians should consider tools like continuous glucose monitoring to reduce variability and prevent severe infections.

Frequently Asked Questions

Why is infection risk elevated in individuals with prediabetes?

Even mild hyperglycemia can impair immune cell function and alter the body's inflammatory response. These physiological changes increase susceptibility to pathogens before a formal diabetes diagnosis is ever made.

How does HbA1c variability impact clinical outcomes?

Frequent fluctuations in blood glucose can induce oxidative stress and damage blood vessels. This instability weakens the immune system's ability to respond to acute infections, leading to higher hospitalization rates.

Is sepsis underreported in diabetes-related deaths?

Yes, medical coding often prioritizes chronic conditions like heart disease as the underlying cause of death. Consequently, the true impact of sepsis and acute infections on diabetes mortality is frequently underestimated in national statistics.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider for any medical concerns. Refer to the latest local and national guidelines for clinical practice.

References

Critchley JA et al. Increased Risk of Infections in People Living With Diabetes. Diabetes. 2026 Jun 06. doi: undefined. PMID: 42250283.

Carey IM, Critchley JA, et al. Effects of long-term HbA1c variability on serious infection risks in patients with type 2 diabetes and the influence of age, sex and ethnicity: A cohort study of primary care data. Diabetes Res Clin Pract. 2024 May;211:111641. doi: 10.1016/j.diabres.2024.111641.

Lin B, et al. Predicting complications for diabetes in South Asians: Beyond convention. Best Pract Res Clin Endocrinol Metab. 2026 May;40(3):102119. doi: 10.1016/j.beem.2026.102119.